Yi-te Hsu to Cell Line, Tumor
This is a "connection" page, showing publications Yi-te Hsu has written about Cell Line, Tumor.
Connection Strength
0.256
-
Nanoparticle delivery of HIF1a siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. Cancer Lett. 2015 Apr 01; 359(1):65-74.
Score: 0.084
-
Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells. Int J Cancer. 2010 Mar 15; 126(6):1353-66.
Score: 0.060
-
AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells. J Lipid Res. 2009 Dec; 50(12):2389-97.
Score: 0.057
-
Differential immunoscreening identifies a glycosylation variant of the epidermal growth factor receptor in ME-180 cervical carcinoma cells. Hybridoma (Larchmt). 2005 Oct; 24(5):225-30.
Score: 0.044
-
A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. Biochem J. 2005 Mar 15; 386(Pt 3):445-51.
Score: 0.011